2019 annual financial data
Atrium Therapeutics 2019 Operating margin
Atrium Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was -747.39%.
Operating income was -17,332,000 USD and net income was -24,734,000 USD.
Operating cash flow was 2,490,000 USD.
Get free Atrium Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,319,000 USD
- Operating income
- -17,332,000 USD
- Net income
- -24,734,000 USD
- Operating cash flow
- 2,490,000 USD